Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRH Regulatory News (CRH)

  • There is currently no data for CRH

CRH Continues Share Buyback Program

6 Nov 2025 07:00

 

CRH (NYSE: CRH), the leading provider of building materials, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders.

Between Aug. 7, 2025 and Nov. 5, 2025, 2.4 million ordinary shares listed on the New York Stock Exchange were repurchased. This brings total cash returned to shareholders under our ongoing share buyback program to $9.4 billion since its commencement in May 2018.

CRH today also announces that it has entered into an arrangement with Santander US Capital Markets LLC to independently conduct a buyback program to repurchase ordinary shares listed on the New York Stock Exchange on CRH’s behalf for an aggregate maximum consideration of up to $0.3 billion (the “Buyback”). The Buyback will commence on Nov. 6, 2025, and will end no later than Feb. 17, 2026.

The maximum number of ordinary shares which may be acquired pursuant to the Buyback is 60,000,000. The purpose of the Buyback is to reduce the share capital of CRH and the repurchased ordinary shares will be cancelled. No repurchases will be made outside of the United States.

The Buyback will be conducted within the parameters prescribed by the relevant buyback safe harbors under the U.S Securities Exchange Act and the UK Market Abuse Regulation (each as amended or supplemented).

Any decision in relation to any future buyback program will be based on an ongoing assessment of the capital needs of the business and general market conditions.

About CRH

CRH (NYSE: CRH) is the leading provider of building materials critical to modernizing infrastructure. With our team of 80,000 people across 4,000 locations, our unmatched scale, connected portfolio, and deep local relationships make us the partner of choice for transportation, water, and reindustrialization projects, shaping communities for a better tomorrow. For more information, visit CRH.com.

Forward Looking Statements

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally, but not always, be identified by the use of words such as "will" or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this document. Forward-looking statements are subject to risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond CRH’s control or precise estimate. Such forward-looking statements include, but are not limited to, expectations related to the structure, timing and volume of the Buyback and manner in which the Buyback will be conducted and expectations related to decisions on any future buyback program. There are important factors that could cause actual outcomes and results to be materially different, including risks and uncertainties relating to CRH described in Item 1.A —Risk Factors of CRH’s Annual Report on Form 10-K for the year ended December 31, 2024 and CRH’s other filings with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. CRH expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.

Tom HolmesHead of Investor Relationstholmes@crh.com

Lauren SchulzChief Communications Officerlschulz@crh.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251105960711/en/

Copyright Business Wire 2025

Date   Source Headline
10th Jan 20249:30 amRNSTransaction in Own Shares
9th Jan 202410:00 amRNSTransaction in Own Shares
8th Jan 20249:45 amRNSTransaction in Own Shares
5th Jan 202410:00 amRNSTransaction in Own Shares
4th Jan 20249:00 amRNSTransaction in Own Shares
4th Jan 20248:30 amRNSCRH completes phase one of $1.1bn lime divestment
4th Jan 20248:30 amRNSHolding(s) in Company
3rd Jan 20244:45 pmRNSTransaction in Own Shares
3rd Jan 20243:00 pmRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 202312:30 pmRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:01 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 202311:15 amRNSTransaction in Own Shares
21st Dec 20233:30 pmRNSTransaction in Own Shares
21st Dec 20237:00 amRNSCRH Continues Share Buyback Program
20th Dec 20233:00 pmRNSTransaction in Own Shares
19th Dec 20233:30 pmRNSDirector/PDMR Shareholding
19th Dec 20233:00 pmRNSTransaction in Own Shares
18th Dec 20233:15 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSCRH proposal to acquire Adbri in Australia
15th Dec 20234:30 pmRNSTransaction in Own Shares
14th Dec 20232:30 pmRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20233:30 pmRNSTransaction in Own Shares
11th Dec 20233:30 pmRNSTransaction in Own Shares
8th Dec 20234:10 pmRNSDirector/PDMR Shareholding
8th Dec 20232:45 pmRNSTransaction in Own Shares
7th Dec 20233:30 pmRNSTransaction in Own Shares
6th Dec 20233:30 pmRNSTransaction in Own Shares
6th Dec 20232:30 pmRNSTransaction in Own Shares
5th Dec 20232:15 pmRNSTransaction in Own Shares
4th Dec 20232:20 pmRNSTransaction in Own Shares
1st Dec 20234:08 pmRNSTransaction in Own Shares
30th Nov 20234:30 pmRNSTotal Voting Rights
30th Nov 20234:30 pmRNSTransaction in Own Shares
30th Nov 20234:30 pmRNSTransaction in Own Shares
30th Nov 20234:20 pmRNSHolding(s) in Company
30th Nov 20233:00 pmRNSDirector/PDMR Shareholding
29th Nov 20232:15 pmRNSTransaction in Own Shares
28th Nov 20233:15 pmRNSTransaction in Own Shares
27th Nov 20233:15 pmRNSDirector/PDMR Shareholding
27th Nov 20232:15 pmRNSTransaction in Own Shares
27th Nov 202311:15 amRNSTransaction in Own Shares
22nd Nov 20232:15 pmRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSCRH agrees $1.1bn divestment of European lime
21st Nov 20234:15 pmRNSTransaction in Own Shares
21st Nov 20237:00 amRNSCRH agrees $2.1bn acquisition in Texas

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.